Today: 20 May 2026
Teradyne stock jumps on AI-driven outlook — here’s what Wall Street is watching next
3 February 2026
1 min read

Teradyne stock jumps on AI-driven outlook — here’s what Wall Street is watching next

New York, Feb 3, 2026, 13:27 EST — Regular session

  • Shares of Teradyne jumped after the company issued a forecast that beat expectations, driven by rising demand for AI-powered chip testing.
  • The company posted fourth-quarter results that exceeded its own guidance range.
  • Traders are now focused on whether the move sticks, turning their attention to orders and momentum heading into 2026.

Teradyne shares jumped 11% to $277.00 in midday trading Tuesday, following a forecast for first-quarter revenue and profit that topped Wall Street expectations. The stock saw a wide range, hitting a high of $312.14 and a low of $249.54.

This matters because Teradyne is tightly linked to the chipmakers’ spending cycle. When they ramp up capacity, particularly for high-end processors and memory for data centers, they invest heavily in test equipment to detect defects and boost yields.

AI is driving the momentum once more. Teradyne’s upbeat forecast hinges on strong demand for compute and memory, fueled by big tech’s ongoing data-center buildouts. At the same time, the surge in chip launches—with growing complexity—has boosted the need for extensive testing, Reuters noted.

Teradyne late Monday posted fourth-quarter revenue of $1.083 billion and non-GAAP earnings of $1.80 per share, driven by $883 million in Semiconductor Test sales. The company reported full-year 2025 revenue at $3.19 billion, a 13% increase over 2024. The earnings release was also included in a U.S. securities filing.

Teradyne’s CEO Greg Smith attributed the strong results to “AI-related demand in compute, networking and memory” within Semiconductor Test. The company expects first-quarter revenue between $1.15 billion and $1.25 billion, with non-GAAP net income per diluted share forecasted at $1.89 to $2.25. Teradyne, Inc.

On the Street, Cantor Fitzgerald analyst C.J. Muse called the earnings a “significant beat and raise,” saying, “We were bullish into this report, but … wow.” Benzinga

The rally shifted attention back to test and measurement stocks following Monday’s strong showing. Teradyne led the pack, outperforming peers like Keysight Technologies, Fortive, and Cohu, MarketWatch data shows.

Still, the setup isn’t without risk. Teradyne’s fate hinges on capital spending, which can shift abruptly if chipmakers halt orders, delay factory expansions, or revise budgets after a demand spike. A rally fueled by guidance can evaporate fast if bookings fail to materialize.

Investors are set to watch closely for new order trends and customer sentiment in the coming weeks. Key dates include SEMICON Korea on Feb. 11 in Seoul and the Chiplet Summit on Feb. 17 in Santa Clara.

Stock Market Today

  • Williams-Sonoma Gains 1.58% as Market Declines, Eyes Upcoming Earnings
    May 19, 2026, 7:31 PM EDT. Williams-Sonoma (WSM) shares rose 1.58% to $171.83, outperforming the S&P 500's 0.67% drop. The stock had declined 16.27% over the past month, lagging the sector's 0.69% loss but behind the S&P 500's 4% gain. Investors await WSM's upcoming earnings report, expected to show $1.80 per share in EPS, down 2.7% year-over-year, with revenue projected to rise 4.25% to $1.8 billion. The company's full-year estimates anticipate 4.75% EPS growth and 4.39% revenue growth. Analyst estimate revisions have nudged EPS projections higher by 0.58% in 30 days, with WSM holding a Zacks Rank #3 (Hold). Valuation indicators show a Forward P/E of 18.27, slightly below industry average, while the PEG ratio of 2.12 exceeds the Retail - Home Furnishings sector average of 1.63.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers
Previous Story

Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers

Qualcomm stock tumbles ahead of earnings as investors weigh analyst note, key executive exit
Next Story

Qualcomm stock tumbles ahead of earnings as investors weigh analyst note, key executive exit

Go toTop